Cargando…
Stable production of recombinant SARS-CoV-2 receptor-binding domain in mammalian cells with co-expression of a fluorescent reporter and its validation as antigenic target for COVID-19 serology testing
SARS-CoV-2 receptor binding domain (RBD) recognizes the angiotensin converting enzyme 2 (ACE2) receptor in host cells that enables infection. Due to its antigenic specificity, RBD production is important for development of serological assays. Here we have established a system for stable RBD producti...
Autores principales: | Arias-Arias, Jorge L., Molina-Castro, Silvia E., Monturiol-Gross, Laura, Lomonte, Bruno, Corrales-Aguilar, Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805376/ https://www.ncbi.nlm.nih.gov/pubmed/36619904 http://dx.doi.org/10.1016/j.btre.2022.e00780 |
Ejemplares similares
-
A Fluorescent Real-Time Plaque Assay Enables Single-Cell Analysis of Virus-Induced Cytopathic Effect by Live-Cell Imaging
por: Arias-Arias, Jorge L., et al.
Publicado: (2021) -
Expression of GPI-anchored SARS-CoV-2 receptor binding domain in mammalian cells for serological use
por: Kernich, M.L., et al.
Publicado: (2021) -
SARS-CoV-2 Multi-Antigen Serology Assay
por: Mazhari, Ramin, et al.
Publicado: (2021) -
Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
por: Meireles, Luciana Regina, et al.
Publicado: (2020) -
Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
por: Wu, Chao, et al.
Publicado: (2021)